• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Applied Dna Scns (NQ: APDN )

    0.4051 -0.0050 (-1.22%)
    Streaming Delayed Price Updated: 1:20 PM EDT, Jul 29, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Applied Dna Scns

    < Previous 1 2 3 4 Next >
    Applied DNA Subsidiary LineaRx Receives Repeat Orders for LinearDNA, Adds Federally Funded Cancer Research Laboratory as CRO Customer
    From Applied DNA Sciences, Inc.
    Via Business Wire
    Research Publication Demonstrates Utility of Applied DNA’s LinearDNA™ in Non-Viral CAR T Manufacturing Systems
    From Applied DNA Sciences, Inc.
    Via Business Wire
    Applied DNA and CLEARED4 Offer Fast, Cost-Effective and Turnkey Integrated Solution for Compliance with OSHA Mandate for COVID-19 Vaccination and Testing
    From Applied DNA Sciences, Inc.
    Via Business Wire
    Applied DNA Submits Request for Emergency Use Authorization to FDA for Linea™ SARS-CoV-2 Mutation Panel
    From Applied DNA Sciences, Inc.
    Via Business Wire
    Ganesha Ecosphere and Applied DNA to Deploy CertainT® Platform to Secure Recycled Polyester Supply Chain
    From Applied DNA Sciences, Inc.
    Via Business Wire
    Applied DNA Implements safeCircle™ COVID-19 Testing Program at Sarah Lawrence College
    From Applied DNA Sciences, Inc.
    Via Business Wire
    Applied DNA Receives Purchase Orders Totaling $1.6 Million to Tag Textile Fibers
    From Applied DNA Sciences, Inc.
    Via Business Wire
    Applied DNA Announces CertainT® Platform Support for TruTrace StrainSecure™ 2.0 for Next Generation Cannabis Tagging, Testing and Tracking
    From Applied DNA Sciences, Inc.
    Via Business Wire
    CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Collaborates to Launch Cutting-Edge Global Cannabis Product Validation, Authentication Platform
    Via CannabisNewsWire
    Topics Cannabis
    Exposures Cannabis
    Applied DNA Enters into Master Services Agreement with Flora Growth for Cannabis Validation and Authentication, Secures First Statement of Work Contract
    From Applied DNA Sciences, Inc.
    Via Business Wire
    Flora Growth Launches Cutting-Edge Global Cannabis Distribution Strategy, Implements Pharmaceutical Standards For Its Supply Chain
    From Flora Growth Corp.
    Via Business Wire
    Applied DNA to Participate at H.C. Wainwright 23rd Annual Global Investment Conference
    From Applied DNA Sciences, Inc.
    Via Business Wire
    Applied DNA Awarded Suffolk County Community College COVID-19 Testing Contract
    From Applied DNA Sciences, Inc.
    Via Business Wire
    Applied DNA Announces Third Quarter Fiscal 2021
    From Applied DNA Sciences, Inc.
    Via Business Wire
    Applied DNA Schedules Fiscal 2021 Third Quarter Financial Results Conference Call and Webcast for Thursday, August 12, 2021
    From Applied DNA Sciences, Inc.
    Via Business Wire
    Applied DNA Awarded The City University of New York (CUNY) COVID-19 Testing Contract
    From Applied DNA Sciences, Inc.
    Via Business Wire
    Applied DNA Sciences and A&E Introduce Anti-Counterfeiting Technology for Sustainable Sewing Threads
    From Applied DNA Sciences, Inc.
    Via Business Wire
    Applied DNA Reports Veterinary COVID-19 Vaccine Candidate Induces Neutralizing Antibodies in 100% of Trial Cohort Against B.1.1.7, P1, and B.1.526 Variants and Sets August 2021 Mink Challenge Trial Launch
    From Applied DNA Sciences, Inc.
    Via Business Wire
    Applied DNA Adds First Summer Camp for safeCircle Pooled COVID-19 Surveillance Testing
    From Applied DNA Sciences, Inc.
    Via Business Wire
    Applied DNA Completes Technical Validation of PCR-based SARS-CoV-2 Mutation-Detection Panel, Highlights Ability to Rapidly Identify Mutations and Probable Variants
    From Applied DNA Sciences, Inc.
    Via Business Wire
    Applied DNA Provides Clarification on Newly Authorized Asymptomatic Serial Screening Indication for LineaTM COVID-19 Assay Kit and Press Release Published 12 May 2021
    From Applied DNA Sciences, Inc.
    Via Business Wire
    Applied DNA Second Fiscal Quarter 2021 Financial Results Feature 384% Year-Over-Year Growth in Revenues
    From Applied DNA Sciences, Inc.
    Via Business Wire
    FDA Grants EUA to Applied DNA LineaTM COVID-19 Assay Kit for Asymptomatic Screening of Individuals with Serial Testing
    From Applied DNA Sciences, Inc.
    Via Business Wire
    Applied DNA Receives CLIA Certification, Enabling High Throughput Diagnostic COVID-19 Testing
    From Applied DNA Sciences, Inc.
    Via Business Wire
    Applied DNA Schedules Fiscal 2021 Second Quarter Financial Results Conference Call and Webcast for Thursday, May 13, 2021
    From Applied DNA Sciences, Inc.
    Via Business Wire
    Applied DNA and Evvivax Announce that LinearDNA™ COVID-19 Vaccine Candidate Booster Yields 5-Fold Average Increase in Neutralizing Antibody Titers in Domestic Felines
    From Applied DNA Sciences, Inc.
    Via Business Wire
    Applied DNA Signs New Contract with U.S. Defense Logistics Agency
    From Applied DNA Sciences, Inc.
    Via Business Wire
    Applied DNA Secures Amendment to Master Services Agreement and Fourth Blanket Purchase Order from Linea™ COVID-19 Assay Kit Customer
    From Applied DNA Sciences, Inc.
    Via Business Wire
    Applied DNA Provides Preliminary Estimated Fiscal Second Quarter 2021 Revenue Range and Business Update
    From Applied DNA Sciences, Inc.
    Via Business Wire
    Applied DNA and Evvivax Announce Positive Preliminary Results of Phase I Clinical Trial for LinearDNA™ COVID-19 Vaccine Candidate in Felines
    From Applied DNA Sciences, Inc. and Takis Biotech/Evvivax
    Via Business Wire
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.